Plenary session - Discontinuing seasonal changes of time

ENVI committee meeting. Vote on the strategy for long-term EU greenhouse gas emissions reduction in accordance with the Paris Agreement

ENVI committee - Vote on Minimum requirements for water reuse

ENVI Committee - Exchange of views with WHO Director-General on the Right to Health in the light of the Human Rights' Week

EP plenary session - Persistent organic pollutants

EP plenary session - Joint debate - Veterinary medicinal products

EP plenary session - Health technology assessment - Report: Soledad Cabezón Ruiz

EP plenary session - explanations of votes

Boleslaw PIECHA in plenary session Week 40 2017 in Strasbourg

Bloeslaw PIECHA in plenary session Week 7 2017 in Strasbourg

Boles?Çaw Grzegorz PIECHA in plenary session week 37 2016 in Strasbourg

Boleslaw PIECHA in plenary session week 27 2016 in Strasbourg

Boleslaw PIECHA in plenary session week 05 2016 in Strasbourg

Boleslaw PIECHA during plenary session week 05 2016 in Strasbourg

Plenary session week 03 2016 in Strasbourg - Votes

During the EP plenary session (3-6 April 2017) in Strasbourg, MEPs debate on stricter rules for the certification and monitoring of medical devices, to ensure full traceability and patient safety, following recent breast and hip implant scandals. They also debate on legislation to tighten up information and ethical requirements for diagnostic medical devices, used for example in pregnancy or DNA testing. Statements by Glenis WILLMOTT (S&amp;D, UK), Rapporteur, Peter LIESE (EPP, DE), Rapporteur, Vytenis ANDRIUKAITIS, Member of the EC in charge of Health and Food Safety, Boleslaw G. PIECHA (ECR, PL), Gesine MEISSNER (ALDE, DE) and Piernicola PEDICINI (EFDD, IT).&nbsp;

Medical devices: extracts from the debate on the report by Peter LIESE ( EPP, DE) and Glenis WILLMOTT (S&D, UK)

PIECHA, Bolesław G. (ECR, PL)

Videoposnetki

Fotografija

Galerija fotografij

Mediji objavljeni za ta oseba

1

Videoposnetki

15

Galerija fotografij

132

Fotografija